PTP4A1 promotes oral squamous cell carcinoma (OSCC) metastasis through altered mitochondrial metabolic reprogramming

Bing Liu1, Wen Si2, Bo Wei3

  • 1Department of Stomatology, Air Force Medical Center of Chinese PLA, Beijing, 100142, China.

Cell Death Discovery
|September 29, 2023
PubMed

Insights

Protein tyrosine phosphatase 4A1 (PTP4A1) drives oral squamous cell carcinoma (OSCC) growth and invasion by reprogramming cell metabolism. Targeting PTP4A1 offers a potential therapeutic strategy for OSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Protein tyrosine phosphatase 4A1 (PTP4A1) is implicated in various pro-oncogenic signaling pathways.
  • Its specific role in oral squamous cell carcinoma (OSCC) pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the role of PTP4A1 in the growth and development of oral squamous cell carcinoma (OSCC).
  • To explore the molecular mechanisms by which PTP4A1 influences OSCC progression.

Main Methods:

  • Quantitative analysis of PTP4A1 expression in OSCC tissues and adjacent non-tumor tissues.
  • In vitro assays to assess the impact of PTP4A1 overexpression on cell growth and invasion.
  • In vivo studies to evaluate PTP4A1's effect on tumor progression.
  • Molecular analyses to identify PTP4A1's binding partners and downstream targets, including PKM2 and ACO2.

Main Results:

  • PTP4A1 is significantly overexpressed in OSCC cells and tissues compared to normal tissues.
  • PTP4A1 overexpression enhances OSCC cell proliferation and invasion in vitro and promotes tumor growth in vivo.
  • PTP4A1 regulates mitochondrial metabolic reprogramming in OSCC cells, contributing to their invasive potential.
  • PTP4A1 interacts with PKM2 to promote its expression and with ACO2 to enhance its degradation.

Conclusions:

  • PTP4A1 plays a critical role in promoting OSCC growth, invasion, and tumor progression.
  • PTP4A1 mediates its effects by modulating mitochondrial metabolism through interactions with PKM2 and ACO2.
  • PTP4A1 represents a promising therapeutic target for oral squamous cell carcinoma treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K